| Literature DB >> 32831026 |
Yasutaka Ishii1, Masahiro Serikawa2, Tomofumi Tsuboi2, Ryota Kawamura2, Ken Tsushima2, Shinya Nakamura2, Tetsuro Hirano2, Ayami Fukiage2, Juri Ikemoto2, Yusuke Kiyoshita2, Sho Saeki2, Yosuke Tamura2, Kazuaki Chayama2.
Abstract
BACKGROUND: In the diagnosis of IgG4-related sclerosing cholangitis (IgG4-SC), differentiation from extrahepatic cholangiocarcinoma (ECC) is extremely important but is still a clinical challenge. This study aimed to elucidate the usefulness of peroral cholangioscopy (POCS) for the differential diagnosis between IgG4-SC and ECC.Entities:
Keywords: Differential diagnosis; Extrahepatic cholangiocarcinoma; IgG4-related sclerosing cholangitis; Peroral cholangioscopy
Mesh:
Substances:
Year: 2020 PMID: 32831026 PMCID: PMC7445926 DOI: 10.1186/s12876-020-01429-2
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Clinical profiles of the 17 patients with IgG4-SC
| Characteristics | Values |
|---|---|
| Age (years) | 63 (51–77) |
| Sex (male: female) | 16: 1 |
| Serological findings | |
| Serum IgG4 (mg/dL) | 264 (21–2590) |
| Elevated serum IgG4 level (≥135 mg/dL), n (%) | 15 (88%) |
| Serum IgG (mg/dL) | 1543 (807–5530) |
| Total bilirubin (mg/dL) | 1.2 (0.6–22.4) |
| ALP (IU/L) | 677 (107–1331) |
| CA19–9 (U/L) | 10 (0–107) |
| Cholangiographic classification, n (%) | |
| Type 1 | 7 (41%) |
| Type 2 | 0 (0%) |
| Type 3 | 2 (12%) |
| Type 4 | 8 (47%) |
| Other organ involvement, n (%) | 15 (88%) |
| Autoimmune pancreatitis | 15 (88%) |
| Sclerosing dacryoadenitis & sialadenitis | 3 (18%) |
| Retroperitoneal fibrosis | 1 (6%) |
| Diagnosis, n (%) | |
| Definite | 15 (88%) |
| Probable | 1 (6%) |
| Possible | 1 (6%) |
| Steroid therapy, n (%) | 14 (82%) |
Data are expressed as number (percentage) or median (range)
IgG4-SC, IgG4-related sclerosing cholangitis; ALP, alkaline phosphatase; CA19–9, carbohydrate antigen 19–9
Fig. 1Cholangioscopic images of IgG4-related sclerosing cholangitis. a Stricture in the middle and hilar bile duct. b Dilated and tortuous vessels spreading around the stricture with smooth mucosal surface. c Stricture in the intrapancreatic bile duct. d Stricture with edematous and smooth mucosal surface
Fig. 2Changes in cholangioscopic images by steroid therapy in a patient with IgG4-related sclerosing cholangitis. Before steroid therapy, cholangiography showed stricture in the hilar bile duct (a), and dilated and tortuous vessels around the stricture (b). Seven days after induction of steroid therapy, stricture (c) and dilatation of the vessels (d) were markedly improved
Fig. 3Cholangioscopic images of infiltrating type extrahepatic cholangiocarcinoma. a Stricture in the middle bile duct. b Dilated and tortuous vessels with caliber alteration and disruption. c Granular mucosa in narrow band imaging. d Stricture in the intrapancreatic bile duct. e Dilated and tortuous vessels with caliber alteration and spontaneous bleeding. f Granular mucosa in narrow band imaging.
Comparison of POCS findings between IgG4-SC and ECC
| IgG4-SC | ECC | ||
|---|---|---|---|
| Mucosal surface (smooth: irregular) | 17: 2 | 9: 44 | < 0.001 |
| Dilated vessels (present: absent) | 11: 8 | 42: 11 | 0.070 |
| Tortuosity (present: absent) | 9: 2 | 35: 7 | 1.000 |
| Abrupt caliber alteration (present: absent) | 2: 9 | 36: 6 | < 0.001 |
| Disruption (present: absent) | 1: 10 | 25: 17 | 0.005 |
| Easily bleeding (present: absent) | 0: 19 | 26: 27 | < 0.001 |
POCS peroral cholangioscopy; IgG4-SC IgG4-related sclerosing cholangitis; ECC extrahepatic cholangiocarcinoma
Relationship between site of stricture, POCS findings and AIP lesion in IgG4-SC patients
| Case | Age rangea | Sexa | IgG4 | Site of stricture | POCS findings | AIP | Pancreatic | Enlargement of | |
|---|---|---|---|---|---|---|---|---|---|
| Dilated vessels | Mucosal surface | ||||||||
| 1 | 70–79 | 1 | 2590 | Extrapancreatic (hilar) | Present | Smooth | Present | Diffuse | Present |
| 2 | 50–59 | 1 | 498 | Extrapancreatic (middle) | Present | Smooth | Present | Segmental | Absent |
| 3 | 50–59 | 1 | 408 | Extrapancreatic (hilar) | Present | Smooth | Present | Diffuse | Present |
| 4 | 50–59 | 1 | 283 | Extrapancreatic (hilar) | Present | Smooth | Present | Diffuse | Present |
| 5 | 60–69 | 2 | 206 | Extrapancreatic (hilar) | Present | Smooth | Absent | – | – |
| 6 | 60–69 | 1 | 194 | Extrapancreatic (hilar) | Absent | Smooth | Absent | – | – |
| 7 | 60–69 | 1 | 186 | Extrapancreatic (hilar) | Present | Smooth | Present | Segmental | Absent |
| 8 | 60–69 | 1 | 21 | Extrapancreatic (hilar) | Present | Irregular | Present | Segmental | Absent |
| 9 | 70–79 | 1 | 127 | Extrapancreatic (hilar) / intrapancreatic | Present / absent | Smooth / smooth | Present | Focal | Present |
| 10 | 70–79 | 1 | 139 | Extrapancreatic (hilar) / intrapancreatic | Present / absent | Irregular / smooth | Present | Focal | Present |
| 11 | 60–69 | 1 | 1620 | Intrapancreatic | Present | Smooth | Present | Focal | Present |
| 12 | 60–69 | 1 | 484 | Intrapancreatic | Absent | Smooth | Present | Focal | Present |
| 13 | 50–59 | 1 | 426 | Intrapancreatic | Absent | Smooth | Present | Diffuse | Present |
| 14 | 60–69 | 1 | 403 | Intrapancreatic | Absent | Smooth | Present | Focal | Present |
| 15 | 70–79 | 1 | 264 | Intrapancreatic | Absent | Smooth | Present | Focal | Present |
| 16 | 60–69 | 1 | 256 | Intrapancreatic | Absent | Smooth | Present | Focal | Present |
| 17 | 60–69 | 1 | 244 | Intrapancreatic | Present | Smooth | Present | Diffuse | Present |
aAge range was used instead of the exact age and sexes were presented by 1 or 2 instead of M or F for securing the patients’ anonymity
POCS peroral cholangioscopy; IgG4-SC IgG4-related sclerosing cholangitis; AIP autoimmune pancreatitis
Comparison of POCS findings in IgG4-SC patients based on the stricture site
| Extrapancreatic | Intrapancreatic | ||
|---|---|---|---|
| ( | ( | ||
| Mucosal surface (smooth: irregular) | 8: 2 | 9: 0 | 0.474 |
| Dilated vessels (present: absent) | 9: 1 | 2: 7 | 0.006 |
| Tortuosity (present: absent) | 7: 2 | 2: 0 | 1.000 |
| Abrupt caliber alteration (present: absent) | 2: 7 | 0: 2 | 1.000 |
| Disruption (present: absent) | 1: 8 | 0: 2 | 1.000 |
| Easily bleeding (present: absent) | 0: 10 | 0: 9 | 1.000 |
POCS peroral cholangioscopy; IgG4-SC IgG4-related sclerosing cholangitis
Comparison of POCS findings between IgG4-SC and ECC based on the stricture site
| Perihilar bilu duct | Distal bile duct | |||||
|---|---|---|---|---|---|---|
| POCS findings | IgG4-SC (n = 9) | ECC ( | IgG4-SC (n = 10a) | ECC ( | ||
| Mucosal surface (smooth: irregular) | 7: 2 | 3: 27 | < 0.001 | 10: 0 | 2: 21 | < 0.001 |
| Dilated vessels (present: absent) | 8: 1 | 24: 6 | 1.000 | 3: 7 | 18: 5 | 0.016 |
| Tortuosity (present: absent) | 6: 2 | 19: 5 | 1.000 | 3: 0 | 16: 2 | 1.000 |
| Abrupt caliber alteration (present: absent) | 2: 6 | 21: 3 | 0.002 | 0: 3 | 15: 3 | 0.015 |
| Disruption (present: absent) | 1: 7 | 14: 10 | 0.041 | 0: 3 | 11: 7 | 0.090 |
| Easily bleeding (present: absent) | 0: 9 | 17: 13 | 0.003 | 0: 10 | 9: 14 | 0.032 |
a The 10 strictures consist of 9 intrapancreatic bile ducts and 1 middle bile duct
POCS peroral cholangioscopy; IgG4-SC IgG4-related sclerosing cholangitis; ECC extrahepatic cholangiocarcinoma